Published in
Taylor & Francis, Expert Opinion on Investigational Drugs, 6(27), p. 543-551
DOI: 10.1080/13543784.2018.1483333
Links
Tools
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease
Journal article published in 2018 by
Loris R. Lopetuso,
Marco Napoli,
Gianenrico Rizzatti 
,
Antonio Gasbarrini
,
Antonio Gasbarrini
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 